|
EP1127882A1
(en)
|
2000-01-25 |
2001-08-29 |
Pfizer Products Inc. |
Tetrazole compounds as thyroid receptor ligands
|
|
US6664291B2
(en)
|
2000-03-31 |
2003-12-16 |
Pfizer, Inc. |
Malonamic acids and derivatives thereof as thyroid receptor ligands
|
|
FI107018B
(fi)
*
|
2000-04-06 |
2001-05-31 |
Ipsat Therapies Oy |
Dermatologinen käyttö ja valmiste
|
|
US8933236B2
(en)
|
2012-05-22 |
2015-01-13 |
Xenon Pharmaceuticals Inc. |
N-substituted benzamides and methods of use thereof
|
|
US6395784B1
(en)
*
|
2000-06-07 |
2002-05-28 |
Bristol-Myers Squibb Company |
Benzamide ligands for the thyroid receptor
|
|
DE10038007A1
(de)
*
|
2000-08-04 |
2002-02-14 |
Bayer Ag |
Neue Amino-und Amido-Diphenylether für Arzneimittel
|
|
US7163918B2
(en)
*
|
2000-08-22 |
2007-01-16 |
New River Pharmaceuticals Inc. |
Iodothyronine compositions
|
|
GB0029100D0
(en)
*
|
2000-11-29 |
2001-01-10 |
Karobio Ab |
Compounds active at the glucocorticoid receptor
|
|
JP2004517851A
(ja)
*
|
2000-12-27 |
2004-06-17 |
バイエル アクチェンゲゼルシャフト |
甲状腺受容体のリガンドとしてのインドール誘導体
|
|
US7504435B2
(en)
|
2001-01-31 |
2009-03-17 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method for stimulating weight loss and/or for lowering triglycerides in patients
|
|
US7144909B2
(en)
|
2001-02-08 |
2006-12-05 |
Karo Bio Ab |
Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
|
|
US6777442B2
(en)
|
2001-03-12 |
2004-08-17 |
Bayer Aktiengesellschaft |
Diphenyl derivatives
|
|
DE10122443A1
(de)
*
|
2001-05-09 |
2002-11-14 |
Bayer Ag |
Amido-Diphenyl-Derivate
|
|
GB0120691D0
(en)
*
|
2001-08-24 |
2001-10-17 |
Karobio Ab |
Novel Compounds
|
|
KR20040027927A
(ko)
|
2001-08-24 |
2004-04-01 |
카로 바이오 아베 |
심장 및 대사 장애의 치료를 위해 주요 환이 치환된갑상선 수용체 길항근
|
|
ATE313325T1
(de)
|
2001-09-26 |
2006-01-15 |
Pfizer Prod Inc |
Indolcaroboxylsäure als thyroidrezeptor-liganden
|
|
EP1471049A4
(en)
*
|
2002-01-30 |
2006-08-16 |
Kissei Pharmaceutical |
NEW THYROIDIAN HORMONE RECEPTOR LIGAND, MEDICINAL PREPARATIONS CONTAINING THE SAME AND USE THEREOF
|
|
GB0208384D0
(en)
*
|
2002-04-11 |
2002-05-22 |
Karobio Ab |
Novel compounds
|
|
GB0215978D0
(en)
*
|
2002-07-10 |
2002-08-21 |
Karobio Ab |
Novel compounds
|
|
ES2305491T3
(es)
*
|
2002-09-19 |
2008-11-01 |
Eli Lilly And Company |
Eteres de diarilo como antagonistas de receptores de opioides.
|
|
EP1477475A1
(en)
*
|
2003-05-16 |
2004-11-17 |
Procorde GmbH |
Compounds for use as a medicine increasing the contractility of a heart, a heart muscle or cells of a heart muscle
|
|
ITRM20030363A1
(it)
*
|
2003-07-24 |
2005-01-25 |
Fernando Goglia |
Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
|
|
US7317109B2
(en)
*
|
2003-11-12 |
2008-01-08 |
Phenomix Corporation |
Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
US7767828B2
(en)
*
|
2003-11-12 |
2010-08-03 |
Phenomix Corporation |
Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
US7576121B2
(en)
*
|
2003-11-12 |
2009-08-18 |
Phenomix Corporation |
Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
KR100918322B1
(ko)
|
2003-11-12 |
2009-09-22 |
페노믹스 코포레이션 |
헤테로시클릭 보론산 화합물
|
|
AU2006249350B2
(en)
|
2003-11-19 |
2012-02-16 |
Metabasis Therapeutics, Inc. |
Thyromimetics for the treatment of fatty liver diseases
|
|
EP2428516A1
(en)
|
2003-11-19 |
2012-03-14 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing thyromimetics
|
|
US7618981B2
(en)
|
2004-05-06 |
2009-11-17 |
Cytokinetics, Inc. |
Imidazopyridinyl-benzamide anti-cancer agents
|
|
US7504413B2
(en)
|
2004-05-06 |
2009-03-17 |
Cytokinetics, Inc. |
N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
|
|
US7795448B2
(en)
|
2004-05-06 |
2010-09-14 |
Cytokinetics, Incorporated |
Imidazoyl-benzamide anti-cancer agents
|
|
UA87854C2
(en)
|
2004-06-07 |
2009-08-25 |
Мерк Энд Ко., Инк. |
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
|
|
US7317024B2
(en)
|
2005-01-13 |
2008-01-08 |
Bristol-Myers Squibb Co. |
Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
|
EP1879881A2
(en)
|
2005-04-14 |
2008-01-23 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
|
|
US7521557B2
(en)
|
2005-05-20 |
2009-04-21 |
Bristol-Myers Squibb Company |
Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
|
|
US7825139B2
(en)
*
|
2005-05-25 |
2010-11-02 |
Forest Laboratories Holdings Limited (BM) |
Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
US7629342B2
(en)
|
2005-06-17 |
2009-12-08 |
Bristol-Myers Squibb Company |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
|
US7572808B2
(en)
|
2005-06-17 |
2009-08-11 |
Bristol-Myers Squibb Company |
Triazolopyridine cannabinoid receptor 1 antagonists
|
|
US7452892B2
(en)
|
2005-06-17 |
2008-11-18 |
Bristol-Myers Squibb Company |
Triazolopyrimidine cannabinoid receptor 1 antagonists
|
|
US7317012B2
(en)
|
2005-06-17 |
2008-01-08 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoind-1 receptor modulators
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
AU2006270914B2
(en)
*
|
2005-07-19 |
2011-01-20 |
Daiichi Sankyo Company, Limited |
Substituted propanamide derivative and pharmaceutical composition containing the same
|
|
CA2617969A1
(en)
*
|
2005-08-10 |
2007-02-15 |
Takeda Pharmaceutical Company Limited |
Therapeutic agent for diabetes
|
|
US7795436B2
(en)
|
2005-08-24 |
2010-09-14 |
Bristol-Myers Squibb Company |
Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists
|
|
US8618115B2
(en)
|
2005-10-26 |
2013-12-31 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them
|
|
US7488725B2
(en)
|
2005-10-31 |
2009-02-10 |
Bristol-Myers Squibb Co. |
Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase IV and methods
|
|
TW200738621A
(en)
*
|
2005-11-28 |
2007-10-16 |
Astrazeneca Ab |
Chemical process
|
|
US7553836B2
(en)
|
2006-02-06 |
2009-06-30 |
Bristol-Myers Squibb Company |
Melanin concentrating hormone receptor-1 antagonists
|
|
AU2007238755B2
(en)
|
2006-04-12 |
2012-07-12 |
Merck Sharp & Dohme Llc |
Pyridyl amide T-type calcium channel antagonists
|
|
WO2007120083A1
(en)
*
|
2006-04-13 |
2007-10-25 |
Astrazeneca Ab |
The use of carboxamide derivatives in the manufacture of a medicament for the treatment of inflammatory, allergic and dermatological conditions
|
|
WO2007132475A1
(en)
*
|
2006-05-15 |
2007-11-22 |
Cadila Healthcare Limited |
Selective tr-beta 1 agonist
|
|
WO2007139589A1
(en)
|
2006-05-26 |
2007-12-06 |
Bristol-Myers Squibb Company |
Sustained release glp-1 receptor modulators
|
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
|
US7727978B2
(en)
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
EP2089355A2
(en)
|
2006-11-01 |
2009-08-19 |
Brystol-Myers Squibb Company |
Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof
|
|
JP2010508358A
(ja)
|
2006-11-01 |
2010-03-18 |
ブリストル−マイヤーズ スクイブ カンパニー |
グルココルチコイド受容体、ＡＰ−１、および／またはＮＦ−κＢ活性の調節剤、並びにその使用
|
|
US7931696B2
(en)
|
2007-01-31 |
2011-04-26 |
BASF SE Ludwigshafen |
Cationic dyes
|
|
WO2008106213A1
(en)
|
2007-02-27 |
2008-09-04 |
Titan Pharmaceuticals, Inc. |
Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome.
|
|
TW200904405A
(en)
|
2007-03-22 |
2009-02-01 |
Bristol Myers Squibb Co |
Pharmaceutical formulations containing an SGLT2 inhibitor
|
|
CN101687873A
(zh)
|
2007-04-17 |
2010-03-31 |
百时美施贵宝公司 |
具有稠合杂环的11β-羟基类固醇Ⅰ型脱氢酶抑制剂
|
|
PE20090696A1
(es)
|
2007-04-20 |
2009-06-20 |
Bristol Myers Squibb Co |
Formas cristalinas de saxagliptina y procesos para preparar las mismas
|
|
US20090011994A1
(en)
|
2007-07-06 |
2009-01-08 |
Bristol-Myers Squibb Company |
Non-basic melanin concentrating hormone receptor-1 antagonists and methods
|
|
JP2010534722A
(ja)
|
2007-07-27 |
2010-11-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
新規グルコキナーゼ活性化薬およびその使用方法
|
|
CN101801954B
(zh)
*
|
2007-09-20 |
2013-10-09 |
Irm责任有限公司 |
作为gpr119活性调节剂的化合物和组合物
|
|
RU2010120671A
(ru)
*
|
2007-10-24 |
2011-11-27 |
Мерк Шарп Энд Домэ Корп. (Us) |
Гетероциклические фениламидные антагонисты кальциевых каналов т-типа
|
|
ES2448839T3
(es)
|
2007-11-01 |
2014-03-17 |
Bristol-Myers Squibb Company |
Compuestos no esteroideos útiles como moderadores de la actividad del receptor de glucocorticoides AP-1 y/o NF-kappa b y uso de los mismos
|
|
GB0725214D0
(en)
*
|
2007-12-24 |
2008-02-06 |
Karobio Ab |
Pharmaceutical compounds
|
|
PE20091928A1
(es)
|
2008-05-29 |
2009-12-31 |
Bristol Myers Squibb Co |
Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos
|
|
US20110301200A1
(en)
*
|
2008-10-27 |
2011-12-08 |
Cadila Healthcare Limited |
Thyroid receptor ligands
|
|
WO2010058730A1
(ja)
|
2008-11-19 |
2010-05-27 |
ポーラ化成工業株式会社 |
シワ改善剤
|
|
WO2010086878A2
(en)
|
2009-01-09 |
2010-08-05 |
Cadila Healthcare Limited |
Thyroid receptor modulators
|
|
CA2756786A1
(en)
|
2009-03-27 |
2010-09-30 |
Bristol-Myers Squibb Company |
Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
|
|
CN102459185B
(zh)
*
|
2009-04-20 |
2015-06-03 |
田边三菱制药株式会社 |
新型甲状腺激素β受体激动剂
|
|
RU2564901C2
(ru)
|
2009-11-13 |
2015-10-10 |
Бристол-Майерс Сквибб Кампани |
Композиции метформина с уменьшенной массой
|
|
CA2780939C
(en)
|
2009-11-13 |
2018-06-12 |
Bristol-Myers Squibb Company |
Bilayer tablet formulations
|
|
RS57926B1
(sr)
|
2009-11-13 |
2019-01-31 |
Astrazeneca Ab |
Formulacije tablete sa trenutnim oslobađanjem
|
|
WO2011103126A1
(en)
*
|
2010-02-17 |
2011-08-25 |
Ampla Pharmaceuticals Inc. |
Treatment of metabolic syndrome with piperidine amides
|
|
WO2011130459A1
(en)
|
2010-04-14 |
2011-10-20 |
Bristol-Myers Squibb Company |
Novel glucokinase activators and methods of using same
|
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
|
EP2560488B1
(en)
|
2010-04-23 |
2015-10-28 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
JP5830534B2
(ja)
|
2010-07-09 |
2015-12-09 |
ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ |
化合物
|
|
CA2804716A1
(en)
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
Chemical compounds
|
|
US8772343B2
(en)
|
2010-07-12 |
2014-07-08 |
Pfizer Limited |
Chemical compounds
|
|
ES2532357T3
(es)
|
2010-07-12 |
2015-03-26 |
Pfizer Limited |
Derivados de sulfonamida como inhibidores de Nav1.7 para el tratamiento del dolor
|
|
EP2593432B1
(en)
|
2010-07-12 |
2014-10-22 |
Pfizer Limited |
N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors
|
|
EP2593431B1
(en)
|
2010-07-12 |
2014-11-19 |
Pfizer Limited |
N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels
|
|
BR112014010271A2
(pt)
|
2011-10-31 |
2017-04-18 |
Xenon Pharmaceuticals Inc |
compostos de benzenossulfonamida e seu uso como agentes terapêuticos
|
|
EP2773641B1
(en)
|
2011-10-31 |
2017-09-27 |
Xenon Pharmaceuticals Inc. |
Biaryl ether sulfonamides and their use as therapeutic agents
|
|
EP2791108B1
(en)
|
2011-12-15 |
2016-07-27 |
Pfizer Limited |
Sulfonamide derivatives
|
|
WO2013102826A1
(en)
*
|
2012-01-04 |
2013-07-11 |
Pfizer Limited |
N-aminosulfonyl benzamides
|
|
CN102718718B
(zh)
*
|
2012-05-31 |
2014-09-24 |
绍兴文理学院 |
一种3,5-二溴-4-（5-苯并咪唑氧基）苯乙酸的制备方法
|
|
CA2878478A1
(en)
*
|
2012-07-06 |
2014-01-09 |
Genentech, Inc. |
N-substituted benzamides and methods of use thereof
|
|
EP2892897A1
(en)
|
2012-09-05 |
2015-07-15 |
Bristol-Myers Squibb Company |
Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
|
|
WO2014039411A1
(en)
|
2012-09-05 |
2014-03-13 |
Bristol-Myers Squibb Company |
Pyrrolone or pyrrolidinone melanin concentrating hormore receptor-1 antagonists
|
|
EP2968280A4
(en)
|
2013-03-14 |
2016-08-10 |
Genentech Inc |
SUBSTITUTED TRIAZOLOPYRIDINES AND METHOD OF USE THEREOF
|
|
RU2015143834A
(ru)
|
2013-03-15 |
2017-04-24 |
Дженентек, Инк. |
Замещенные бензоксазолы и способы их применения
|
|
WO2015027021A1
(en)
|
2013-08-22 |
2015-02-26 |
Bristol-Myers Squibb Company |
Imide and acylurea derivatives as modulators of the glucocorticoid receptor
|
|
CA2931732A1
(en)
|
2013-11-27 |
2015-06-04 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
CN103709094B
(zh)
*
|
2014-01-07 |
2016-04-06 |
厦门大学 |
4-苯氧基苯甲酰胺类化合物及其制备方法和应用
|
|
EP3166939B1
(en)
|
2014-07-07 |
2019-06-05 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
KR20180008761A
(ko)
|
2015-05-22 |
2018-01-24 |
제넨테크, 인크. |
치환된 벤즈아미드 및 이의 이용 방법
|
|
WO2017035271A1
(en)
|
2015-08-27 |
2017-03-02 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
SG10202007787RA
(en)
|
2015-09-28 |
2020-09-29 |
Genentech Inc |
Therapeutic compounds and methods of use thereof
|
|
WO2017091592A1
(en)
|
2015-11-25 |
2017-06-01 |
Genentech, Inc. |
Substituted benzamides useful as sodium channel blockers
|
|
EP3436432B1
(en)
|
2016-03-30 |
2021-01-27 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
ES2940611T3
(es)
*
|
2016-04-18 |
2023-05-09 |
Novartis Ag |
Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP
|
|
IL264765B2
(en)
*
|
2016-08-12 |
2024-03-01 |
Univ Oregon Health & Science |
Amide compounds, their pharmaceutical preparations and methods of using them
|
|
MX2019004232A
(es)
|
2016-10-17 |
2019-08-01 |
Genentech Inc |
Compuestos terapéuticos y métodos para utilizarlos.
|
|
MX2019005730A
(es)
|
2016-11-21 |
2019-10-21 |
Viking Therapeutics Inc |
Metodo para tratar enfermedad de almacenamiento de glucogeno.
|
|
CN106588690B
(zh)
*
|
2016-12-19 |
2019-06-04 |
广西中医药大学 |
毛鸡骨草甲素Abrusamide的制备方法
|
|
CN110546148A
(zh)
|
2017-03-24 |
2019-12-06 |
基因泰克公司 |
作为钠通道抑制剂的4-哌啶-n-(嘧啶-4-基)色满-7-磺酰胺衍生物
|
|
EA201992703A1
(ru)
|
2017-06-05 |
2020-04-15 |
Вайкинг Терапьютикс, Инк. |
Композиции для лечения фиброза
|
|
EP3683306A4
(en)
|
2017-09-14 |
2021-06-09 |
Riken |
RETINAL TISSUE PRODUCTION PROCESS
|
|
EP3697758B1
(en)
*
|
2017-10-17 |
2022-07-06 |
Novartis AG |
Sulphonamides and compositions thereof for treating conditions associated with nlrp activity
|
|
CN111518770B
(zh)
|
2017-12-19 |
2023-01-06 |
北京吉源生物科技有限公司 |
一种表达glp1和fgf21的干细胞及其用途
|
|
WO2019165290A1
(en)
|
2018-02-26 |
2019-08-29 |
Genentech, Inc. |
Pyridine-sulfonamide compounds and their use against pain and related conditions
|
|
AU2019238090A1
(en)
|
2018-03-22 |
2020-10-08 |
Viking Therapeutics, Inc. |
Crystalline forms and methods of producing crystalline forms of a compound
|
|
EP3774801A1
(en)
|
2018-03-30 |
2021-02-17 |
F. Hoffmann-La Roche AG |
Fused ring hydro-pyrido compounds as sodium channel inhibitors
|
|
CA3105626A1
(en)
|
2018-07-19 |
2020-01-23 |
Astrazeneca Ab |
Methods of treating hfpef employing dapagliflozin and compositions comprising the same
|
|
CN113423684A
(zh)
|
2018-12-12 |
2021-09-21 |
速通医疗公司 |
新型拟甲状腺素药
|
|
US11667606B2
(en)
|
2019-03-01 |
2023-06-06 |
Autobahn Therapeutics, Inc. |
Thyromimetics
|
|
WO2020184720A1
(ja)
|
2019-03-13 |
2020-09-17 |
大日本住友製薬株式会社 |
移植用神経網膜の品質を評価する方法及び移植用神経網膜シート
|
|
US20220306630A1
(en)
*
|
2019-08-06 |
2022-09-29 |
Bristol-Myers Squibb Company |
AGONISTS OF ROR GAMMAt
|
|
JPWO2022054924A1
(US07585860-20090908-C00162.png)
|
2020-09-11 |
2022-03-17 |
|
|
|
WO2022054925A1
(ja)
|
2020-09-11 |
2022-03-17 |
国立研究開発法人理化学研究所 |
神経網膜を含む細胞凝集体とマトリクスとを含む複合体及びその製造方法
|
|
CA3238664A1
(en)
|
2021-11-19 |
2023-05-25 |
Riken |
Production method for sheet-like retinal tissue
|
